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Abstract
Background: Awareness of risks associated with radiation exposure to patients and medical staff has 
significantly increased. It has been reported before that the use of advanced three-dimensional electro-
anatomical mapping (EAM) system significantly reduces fluoroscopy time, however this study aimed for 
zero or near zero fluoroscopy ablation to assess its feasibility and safety in ablation of atrial fibrillation 
(AF) and other tachyarrhythmias in a “real world” experience of a single tertiary care center.
Methods: This was a single-center study where ablation procedures were attempted without fluoroscopy 
in 34 consecutive patients with different tachyarrhythmias under the support of EAM system. When 
transseptal puncture (TSP) was needed, it was attempted under the guidance of intracardiac echocar-
diography (ICE). 
Results: Among 34 patients consecutively enrolled in this study, 28 (82.4%) patients were referred for 
radiofrequency ablation (RFA) of AF, 3 (8.8%) patients for ablation of right ventricular outflow tract 
(RVOT) ventricular extrasystole (VES), 1 (2.9%) patient for ablation of atrioventricular nodal reentry 
tachycardia (AVNRT), 2 (5.9%) patients for typical atrial flutter ablation. In 21 (62%) patients the en-
tire procedure was carried out without the use of fluoroscopy. Among 28 AF patients, 15 (54%) patients 
underwent ablation without the use of fluoroscopy and among these 15 patients, 10 (67%) patients 
required TSP under ICE guidance while 5 (33%) patients the catheters were introduced to left atrium 
through a patent foramen ovale. In 13 AF patients, fluoroscopy was only required for double TSP. The 
total procedure time of AF ablation was 130 ± 50 min. All patients referred for atrial flutter, AVNRT, 
and VES of the RVOT ablation did not require any fluoroscopy. 
Conclusions: This study demonstrates the feasibility of zero or near zero fluoroscopy procedure includ-
ing TSP with the support of EAM and ICE guidance in a “real world” experience of a single tertiary 
care center. When fluoroscopy was required, it was limited to TSP hence keeping the radiation dose very 
low. (Cardiol J 2019; 26, 3: 226–232)
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three-dimensional electroanatomical mapping
Introduction
Recently, the awareness of risks associated 
with radiation exposure to patients and medical 
staff has significantly increased. The risks of injury 
hazard by medical radiation exposure are caused 
by deterministic (dose-dependent) effects such as 
radiation injury to the skin secondary to high peak 
skin doses and by stochastic (non dose-dependent) 
effects such as increased radiation-induced cancer 
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risk and genetic effects [1, 2]. These risks are of 
particular concern for young or obese patients and 
for patients who undergo long, repeated or complex 
procedures [3, 4]. Moreover, operators, nurses 
and technical staff are exposed to significant and 
potentially hazardous doses of ionizing radiation on 
a daily basis resulting in life-time risk for malig-
nancy, cataract and congenital defects [5, 6]. Since 
the beginning of interventional electrophysiology 
for diagnosis and therapy of cardiac arrhythmias, 
fluoroscopy techniques have been widely used to 
navigate catheters within the heart and the ves-
sels and to monitor their position. In recent years, 
technical developments have led to the routine 
and wide-spread use of non-fluoroscopic three-
dimensional (3D) electro-anatomical navigation and 
mapping systems for radiofrequency ablation (RFA) 
of tachyarrhythmias including atrial fibrillation 
(AF) resulting in a significant reduction of radia-
tion dose during mapping and ablation of complex 
arrhythmias [7–13]. Minimizing the exposure to ra-
diation is recommended by the American College of 
Cardiology teaching the ALARA principle — keep-
ing the radiation “as low as reasonably achievable” 
[14, 15]. It has been reported before that the use 
of 3D electro-anatomical mapping (EAM) system 
significantly reduces fluoroscopy time and radiation 
dose however the aim of this study was to assess 
the feasibility and the safety of zero or near zero 
fluoroscopy mapping and ablation of AF and other 
tachyarrhythmias in a “real world” experience of 
a single tertiary care center. 
Methods
Among patients referred to the Division of Ar-
rhythmia and Electrophysiology at the University 
Heart Center in Zurich, Switzerland, 34 patients 
were enrolled consecutively in the study. Majority 
of patients in the study group were referred for 
RFA of AF (28 patients). Few patients with other 
tachyarrhythmias were also enrolled: 2 with typical 
atrial flutter (AFL), 3 with idiopathic ventricular 
extrasystole (VES) from the right ventricular 
outflow tract (RVOT) and 1 with atrioventricular 
nodal reentry tachycardia (AVNRT). Percutaneous 
access for all catheters was via the right femoral 
vein. Written informed consent was obtained from 
all patients. All clinical cardiac characteristics as 
well as important comorbidities were recorded 
according to the regulations of the local Institu-
tional Committee on Human Research. This was 
a single-center study.
Procedural safety
Pre-procedure and post-procedure patient 
management, as well as intra-procedure antico-
agulation policy were in accordance with practice 
guidelines and our hospital policies.
All operators performing the ablation proce-
dures were senior staff with experience in catheter 
navigation under 3D EAM system. Different im-
aging modalities were used including intracardiac 
echocardiography (ICE), transesophageal echocar-
diography (TEE) and magnetic resonance imaging 
(MRI) as needed. Although the intention was to 
perform zero fluoroscopy procedure, all operators 
were allowed to use fluoroscopy if required for 
patient safety and that is why fluoroscopy was used 
in 13 patients.
Catheter ablation of AF
Patients scheduled for AF ablation underwent 
MRI of the pulmonary veins (PV) and left atrium 
(LA) before the procedure to identify anatomical 
variants, to assess the exact anatomical position 
and size of PV ostia and to merge with CARTO 3 
system (Biosense Webster, Diamond Bar, CA, 
USA) (Fig. 1). TEE was also done before the 
procedure to rule out thrombi in the LA and to 
document the presence of a patent foramen ovale 
(PFO). For mapping and ablation, a 3D EAM 
system, CARTO 3 system (Biosense Webster, 
Diamond Bar, CA, USA) was used. All procedures 
were performed under conscious sedation using 
midazolam and fentanyl.
A 6 F steerable decapolar Dynamic XT cath-
eter (Boston Scientific, Marlborough, MA, USA) 
was positioned in the coronary sinus for mapping 
and pacing purposes. For ablation an 8 F Ther-
mocool bi-directional (D-F curve) catheter was 
used (Biosense Webster, Diamond Bar, CA, USA). 
A steerable 7 F multipolar Lasso catheter (Bio-
sense Webster, Diamond Bar, CA, USA) was used 
for mapping of the PVs and to confirm procedural 
endpoint of electrical isolation. The transseptal 
punctures (TSP) were performed using Brock-
enborough (BRK-1) needle (St. Jude Medical, 
St. Paul, MN, USA) through 8 F Preface guiding 
sheath (Biosense Webster, Diamond Bar, CA, USA) 
and was attempted under the guidance of Acuson 
Acuna ultrasound catheter (Siemens Healthcare, 
Erlangen, Germany). 
Catheter positioning into and within the car-
diac chamber of interest as well as mapping and ab-
lation were attempted without fluoroscopy with the 
support of EMA. A fast anatomical map was created 
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using the Lasso catheter to create a 3D geometry 
of LA and PV without fluoroscopy. PV isolation was 
performed by wide-area circumferential point-by-
point RFA around the ostia of the ipsilateral PVs. 
The procedural endpoint was electrical isolation 
(entrance and exit block) documented using the 
Lasso mapping catheter. Power was limited to 30 
Watts and flow was adjusted from 2 mL/min up to 
30 mL/min to achieve this power. In patients with 
a history of typical AFL (5 patients in our group) 
a cavotricuspid isthmus ablation line was added. If 
sinus rhythm was not restored following ablation, 
the patient was cardioverted with a direct current 
shock.
In 5 patients the catheters were introduced 
to LA through a PFO without the need of TSP. 
In 3 patients with PFO, ICE was used to allocate 
the site of PFO that was crossed by the ablation 
catheter along with its Preface guiding sheath. In 
2 patients with PFO, the ablation catheter (through 
the Preface guiding sheath) was brought to the 
superior vena cava and dragged caudally till the 
typical jump to the foramen ovale region was de-
tected with 3D EAM. Then the ablation catheter 
along with its guiding sheath were advanced into 
the LA. 
In 1 patient, TSP was done without the use 
of fluoroscopy or ICE as following: first a fast 
anatomical map was created using the ablation 
catheter (through Preface guiding sheath) to cre-
ate a 3D right atrium and vena cava geometry. The 
His bundle region was marked. Then the Preface 
guiding sheath (with only the tip of ablation cath-
eter exposed out of the sheath) was brought to 
the superior vena cava and dragged caudally till 
the typical jump to the foramen ovale region was 
detected and marked with 3D EAM. The ablation 
catheter was pulled out of the guiding sheath and 
the sheath was kept in same place of the foramen 
ovale region. The dilator of the guiding sheath and 
the Brockenbrough (BRK-1) needle (with metal 
arrow on needle hub and sheath sidearm pointing 
at 4 o’clock) were inserted within the sheath and 
TSP was done successfully. 
Catheter ablation of RVOT VES
Thermocool bi-directional (D-F curve) cathe-
ter was used (Biosense Webster, Diamond Bar, CA, 
USA) to create RVOT geometry. Earliest electrical 
activation region was mapped in 3D EAM system 
and VES was successfully ablated.
Catheter ablation of typical AFL
A 6 F steerable decapolar Dynamic XT cath-
eter (Boston Scientific, Marlborough, MA, USA) 
was positioned in the coronary sinus. Thermocool 
bi-directional (D-F curve) catheter was used (Bio-
sense Webster, Diamond Bar, CA, USA) to create 
right atrium geometry with the tricuspid annulus 
and both vena cava superior and inferior. The His 
Figure 1. Left panel showing the three-dimensional electroanatomical CARTO maps (Biosense Webster, Diamond 
Bar, CA, USA) of right (gray) and left (green) atria with coronary sinus (blue) and right panel with three-dimensional 
reconstruction from magnetic resonance imaging. Both panels show the images from the anteroposterior view.
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bundle region was marked. An ablation line was 
performed in the region of cavotricuspid isthmus 
creating a bi-directional block.
Catheter ablation of AVNRT
A Navistar 4 mm (D Curve) ablation catheter 
(Biosense Webster, Diamond Bar, CA, USA) was 
used to create right atrium geometry. The His 
bundle region was marked and the anatomical and 
characteristical electrical slow pathway region was 
identified and successfully ablated.
Results
Thirty four patients were consecutively en-
rolled in the study. The baseline clinical charac-
teristics are summarized in Table 1. All patients 
had a structurally normal heart with preserved left 
ventricular systolic function and without valvular 
heart disease. Twenty eight (82.4%) patients were 
referred for catheter ablation of AF (22 with par-
oxysmal and 6 with persistent AF). The remaining 
6 patients were referred either for ablation of typi-
cal AFL, VES from the RVOT or AVNRT (Table 2). 
Among AF patients, 5 patients had additional 
typical AFL. 39% of AF patients had anatomical 
variants of the PVs and 18% had a PFO (Table 3).
In 21 (62%) patients the entire procedure was 
carried out without the use of fluoroscopy. Among 
the 28 AF patients, the procedure was performed 
with zero fluoroscopy in 15 (54%) patients. Ten 
(67%) AF patients required TSP under ICE guid-
ance to access the LA while in 5 (33%) patients 
the catheters were introduced into the LA through 
a PFO (in 3 patients with the help of ICE and in 
2 without as previously described). All patients in 
the series referred for atrial AFL, AVNRT, and VES 
of the RVOT ablation did not require fluoroscopy 
(Fig. 2). 
Procedure time and fluoroscopy use
The total procedure time for ablation of AF was 
130 ± 50 min. Most of the time (59.9 ± 20 min) 
was required for the ablation of PVs (Table 4). 
Fluoroscopy was required in 13 AF patients solely 
for double TSP in order to safely access the LA 
despite the availability of ICE. In our patient se-
ries fluoroscopy was only used for the TSPs. The 
median total fluoroscopy time was 2.6 ± 2.2 min 
and the dose area product 13 ± 27 gray × cm2. 
Mapping of the LA and wide-area circumferential 
ablation around the PVs did not require the use of 
fluoroscopy.
Table 2. Types of arrhythmias.
Atrial fibrillation: 28 (82.4%)
Paroxysmal AF 22
Persistent AF 6
Atrial flutter:
Atrial flutter alone 2 (5.9%)
In combination with paroxysmal AF 4 (11.8%)
In combination with persistent AF 1 (2.9%)
VES RVOT 3 (8.8%)
AVNRT 1 (2.9%)
AF — atrial fibrillation; VES — ventricular extrasystole; RVOT — 
right ventricular outflow tract; AVNRT — atrioventricular reentrant 
tachycardia
Table 3. Pulmonary vein anatomy.
Normal anatomy (2 right,  
2 left pulmonary veins)
17 (61.0%)
Common left ostium 6 (21.4%)
Three right pulmonary veins 5 (17.9%)
Patent foramen ovale 5 (17.9%)
Table 4. Procedural and fluoroscopy times.
Total procedure time [min] 130 ± 50
Catheter placement [min] 20 ± 5
Left atrial mapping [min] 15 ± 8
Left atrial ablation [min] 59.9 ± 20
Total X-ray time [min] 2.6 ± 2.2
Dose area product [Gray × cm2] 13 ± 27
Table 1. Patient characteristics.
Number of patients 34 (100%)
Age [years] 56 ± 12.4
Male 24 (71%)
Left atrium diameter [mm] 41.7 ± 0.6
Hypertension 15 (44.1%)
Coronary artery disease 6 (17.7%)
Diabetes mellitus 1 (2.9%)
CVA/TIA 5 (14.7%)
Heart failure 2 (5.9%)
CVA — cerebrovascular attack; TIA — transient ischemic attack
Procedural endpoint and outcome
All procedures were successfully carried out. 
In AF patients, isolation of all PVs was validated 
using the Lasso catheter placed at each ostium 
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which realized confirmation of isolation of all PVs 
by documentation of entrance and exit block. For 
typical AFL ablation, the cavotricuspid isthmus was 
checked for bidirectional block. VES of the RVOT 
was ablated successfully with complete abolition 
of VES. After slow pathway ablation, there was 
no AVNRT inducible at rest or under adrenergic 
stimulation with isoprenalin.
One patient in whom AF ablation was per-
formed without fluoroscopy and after uncompli-
cated TSP guided by ICE had a post-procedural 
pericardial tamponade which was resolved by 
immediate percutaneous drainage. No other com-
plications occurred in this study group. 
Discussion 
Over the last years, the awareness of radia-
tion hazards to patients and professional staff has 
significantly increased. Reduction of radiation 
exposure in electrophysiological procedures, such 
as AF ablation, should always be considered. 3D 
EAM systems with their constant updating tech-
nologies that allows precise location visualization 
of diagnostic and ablation catheters and allows 
fast anatomical mapping of cardiac chambers have 
shown to contribute to significant reduction of 
fluoroscopy time and radiation dose. Lee et al. 
[16] have shown that the use of contact force-
sensing catheter during AF ablation significantly 
reduces fluoroscopy times by 77%, radiation dose 
by 71%, and procedural time by 19%. However 
the median fluoroscopy time in the force-sensing 
catheter group was 9.5 min and median radiation 
dose was 1043.5 mGy × cm2. This study showed 
that zero or near zero fluoroscopy was feasible in 
patients referred for catheter ablation of AF and 
other tachyarrhythmias with the support of EAM 
and ICE guidance. Fluoroscopy was only used 
if required and limited to assist in difficult TSP 
hence keeping the radiation time and dose very low 
(2.6 ± 2.2 min and 13 ± 2.7 gray × cm2, respectively). 
Catheter placement, navigation, mapping and abla-
tion can be done with the support of EAM. TSP can 
be done safely under the guidance of ICE imaging. 
The LA can be accessed safely in the presence of 
PFO under ICE guidance without the need of TSP.
Other groups have shown feasibility of fluoros-
copy-free PV isolation in 26 out of 30 consecutive 
patients with a documented PFO [17]. Bulava et 
al. [18] demonstrated the feasibility of zero fluor-
oscopy ablation in 40 patients with paroxysmal 
AF using ICE imaging and 3D EAM mapping with 
contact force measurements. Reddy et al. [19] 
showed complete fluoroless catheter ablation of 
paroxysmal AF in 20 patients using combination 
of ICE and 3D EAM system.
In a series of 19 out of 21 patients, Ferguson et al. 
[20] demonstrated that AF ablation was feasible 
without fluoroscopic guidance. Double TSP were 
performed with ICE guidance and facilitated by electro-
cautery. In 2 cases fluoroscopy was used to assist TSP. 
Figure 2. Atrial fibrillation (AF) ablation and fluoroscopy use.
Total of AF ablation 28 AF patients
Without Fluo
15 patients
Without TSP
5 patients
With ICE
3 patients
With ICE
9 patients
With ICE
7 patients
Without TSP
0 patients
With TSP
10 patients
With TSP
13 patients
With Fluo
13 patientsFluoroscopy (Fluo)
Transseptal puncture (TSP)
Intracardiac
echocardiography (ICE)
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Kerst et al. [21] showed in a group of 
30 patients that contact force-controlled zero 
fluoroscopy catheter ablation is generally feasible 
in right-sided and left atrial cardiac arrhythmias.
Hindricks et al. [22] compared the results of 
catheter ablation to cure typical AFL using conven-
tional ablation strategy and electro-anatomically 
guided mapping and ablation. They found that 
cavotricuspid isthmus ablation to cure typical AFL 
was highly effective and safe, both in conventional 
and electro-anatomically guided ablation group. 
The use of EAM system significantly reduced 
fluoroscopy exposure time by almost 50%, however 
this was at the expense of an increased cost of the 
procedure.
Limitations of the study
Because of the small number of patients in the 
resent study group, it was difficult to make con-
clusions about safety. A much larger multi-center 
study would be needed to determine any true 
increase in the rate of catheter-related complica-
tions as a result of using this technique given that 
the incidence of cardiac tamponade and catheter 
perforation during AF ablation is low.
Conclusions
This study demonstrates the feasibility of an 
entire zero or near zero fluoroscopy procedure 
including transseptal puncture for patients with 
AF and other tachyarrhythmias under the support 
of 3D EAM systems and ICE imaging in a “real 
world” experience of a single tertiary care center. 
When fluoroscopy was required, it was limited to 
transseptal puncture and hence keeping the radia-
tion dose very low. 
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